Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 1
2023 2
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2 results

Results by year

Filters applied: . Clear all
Page 1
Ambulatory and hospitalized patients with suspected and confirmed mpox: an observational cohort study from Brazil.
Silva MST, Coutinho C, Torres TS, Peixoto E, Ismério R, Lessa F, Nunes EP, Hoagland B, Echeverria Guevara AD, Bastos MO, Ferreira Tavares IC, Diniz Ribeiro MP, Meneguetti Seravalli Ramos MR, Andrade HB, Lovetro Santana AP, Santini-Oliveira M, Santos Netto JB, Reges P, Magalhães MA, Silva Rosadas LA, Nazer S, Velasque L, Cardoso SW, da Silva EE, Veloso VG, Wakimoto MD, Grinsztejn B; INI-Fiocruz Mpox Study Group. Silva MST, et al. Lancet Reg Health Am. 2022 Dec 13;17:100406. doi: 10.1016/j.lana.2022.100406. eCollection 2023 Jan. Lancet Reg Health Am. 2022. PMID: 36776570 Free PMC article.
Intravenous Ceftriaxone on an Outpatient Basis in the Treatment of Ocular Syphilis.
Gomes E Silva A, Alcântara Pedroso L, Veiga Costa F, de Moraes Perlingeiro R, Peixoto de Castro Oliveira P, Biancardi Barreto AL, Luiz Land Curi A. Gomes E Silva A, et al. Among authors: peixoto de castro oliveira p. Ocul Immunol Inflamm. 2024 Sep;32(7):1284-1286. doi: 10.1080/09273948.2023.2232443. Epub 2023 Aug 15. Ocul Immunol Inflamm. 2024. PMID: 37582224